IL6 and bone cancer: For example, spinal LXA4 and its aspirin-triggered form reduced TNF, IL-1β and IL-6 mRNA and protein levels in the DRG in a neuropathic pain model [12] and in the spinal cord in a model of bone cancer-induced pain [13].